Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 2 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Conditioning | 2 |
| Memory | 2 |
| Drug Therapy | 1 |
| Eye Movements | 1 |
| Fear | 1 |
| Learning Processes | 1 |
| Physiology | 1 |
| Posttraumatic Stress Disorder | 1 |
| Prevention | 1 |
| Responses | 1 |
| Stimuli | 1 |
| More ▼ | |
Source
| Learning & Memory | 2 |
Author
| Bach, Dominik R. | 2 |
| Clem, Roger L. | 1 |
| Homan, Philipp | 1 |
| Lin, Qi | 1 |
| Murrough, James W. | 1 |
| Schiller, Daniela | 1 |
| Soleimani, Laili | 1 |
| Zimmermann, Josua | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkZimmermann, Josua; Bach, Dominik R. – Learning & Memory, 2020
A reminder can render consolidated memory labile and susceptible to amnesic agents during a reconsolidation window. For the case of threat memory (also termed fear memory), it has been suggested that extinction training during this reconsolidation window has the same disruptive impact. This procedure could provide a powerful therapeutic principle…
Descriptors: Physiology, Responses, Conditioning, Eye Movements
Homan, Philipp; Lin, Qi; Murrough, James W.; Soleimani, Laili; Bach, Dominik R.; Clem, Roger L.; Schiller, Daniela – Learning & Memory, 2017
The alpha-1 adrenoreceptor antagonist prazosin has shown promise in the treatment of post-traumatic stress disorder (PTSD) symptoms, but its mechanisms are not well understood. Here we administered prazosin or placebo prior to threat conditioning (day 1) and tested subsequent extinction (day 2) and reextinction (day 3) in healthy human…
Descriptors: Posttraumatic Stress Disorder, Memory, Stimuli, Drug Therapy
